Total Payments
$690.11
2024 Payments
$155.53
Companies
11
Transactions
28
Medicare Patients
1,153
Medicare Billing
$116,081
Payment Breakdown by Category
Food & Beverage$690.11 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $690.11 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $230.51 | 8 | $0 (2024) |
| Allergan Inc. | $211.11 | 4 | $0 (2018) |
| Lilly USA, LLC | $86.15 | 5 | $0 (2024) |
| Genentech USA, Inc. | $53.78 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $21.92 | 2 | $0 (2017) |
| Astellas Pharma US Inc | $20.00 | 1 | $0 (2021) |
| Phathom Pharmaceuticals, Inc. | $16.85 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $14.99 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $12.04 | 1 | $0 (2020) |
| PFIZER INC. | $11.54 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $155.53 | 9 | Lilly USA, LLC ($86.15) |
| 2022 | $17.24 | 1 | Novo Nordisk Inc ($17.24) |
| 2021 | $124.29 | 7 | Novo Nordisk Inc ($72.59) |
| 2020 | $30.20 | 2 | Genentech USA, Inc. ($18.16) |
| 2019 | $103.14 | 1 | Novo Nordisk Inc ($103.14) |
| 2018 | $117.80 | 2 | Allergan Inc. ($102.34) |
| 2017 | $141.91 | 6 | Allergan Inc. ($108.77) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.83 | General |
| 07/24/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Obesity | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Obesity | ||||||
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 03/24/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.24 | General |
| 10/07/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.90 | General |
| 09/14/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.80 | General |
| 08/05/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: UROLOGY | ||||||
| 05/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Diabetes | ||||||
| 04/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Diabetes | ||||||
| 02/16/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Virology & Specialty Care | ||||||
| 01/29/2021 | PFIZER INC. | PREMARIN (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: WOMENS HEALTH | ||||||
| 11/17/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Virology & Specialty Care | ||||||
| 03/11/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Central Nervous System | ||||||
| 11/14/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $103.14 | General |
| 11/12/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Virology & Specialty Care | ||||||
| 05/17/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $102.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2017 | Allergan Inc. | NAMENDA XR (Drug), NAMZARIC | Food and Beverage | In-kind items and services | $92.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 212 | 375 | $125,876 | $29,216 |
| 2022 | 5 | 277 | 430 | $123,554 | $30,746 |
| 2021 | 9 | 354 | 431 | $115,482 | $29,280 |
| 2020 | 9 | 310 | 419 | $103,522 | $26,839 |
Total Patients
1,153
Total Services
1,655
Medicare Billing
$116,081
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 239 | $89,334 | $18,536 | 20.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 56 | 56 | $21,381 | $7,052 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 43 | $11,326 | $1,856 | 16.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 17 | 17 | $2,635 | $1,213 | 46.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $1,200 | $559.55 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 221 | $73,964 | $15,586 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $21,789 | $7,973 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 87 | $21,137 | $4,530 | 21.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $5,488 | $1,851 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 31 | $1,176 | $805.96 | 68.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 130 | $33,930 | $8,138 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 59 | 59 | $22,361 | $7,743 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 83 | $30,710 | $7,449 | 24.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 31 | 31 | $5,673 | $2,023 | 35.7% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 40 | 40 | $6,000 | $1,540 | 25.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 26 | 28 | $10,416 | $1,160 | 11.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 33 | 33 | $1,650 | $541.08 | 32.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 16 | $4,192 | $505.91 | 12.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 11 | 11 | $550.00 | $180.40 | 32.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 90 | 155 | $45,570 | $8,974 | 19.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 49 | 49 | $16,577 | $5,628 | 34.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 60 | 99 | $20,937 | $4,668 | 22.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 11 | 11 | $3,982 | $2,472 | 62.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 22 | 24 | $7,479 | $1,985 | 26.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 28 | $5,628 | $1,356 | 24.1% |
About Dr. Thomas Zelonis, DO
Dr. Thomas Zelonis, DO is a Family Medicine healthcare provider based in Bethel Park, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710074349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Zelonis, DO has received a total of $690.11 in payments from pharmaceutical and medical device companies, with $155.53 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($690.11).
As a Medicare-enrolled provider, Zelonis has provided services to 1,153 Medicare beneficiaries, totaling 1,655 services with total Medicare billing of $116,081. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bethel Park, PA
- Active Since 10/06/2006
- Last Updated 10/08/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1710074349
Products in Payments
- VRAYLAR (Drug) $113.64
- NAMENDA XR (Drug) $92.94
- Xofluza (Drug) $53.78
- MOUNJARO (Drug) $39.12
- Ozempic (Drug) $38.89
- ZEPBOUND (Drug) $30.20
- FARXIGA (Drug) $21.92
- MYRBETRIQ (Drug) $20.00
- VOQUEZNA (Drug) $16.85
- JARDIANCE (Drug) $16.83
- Rybelsus (Drug) $16.71
- TRELEGY ELLIPTA (Drug) $14.99
- AJOVY (Biological) $12.04
- PREMARIN (Drug) $11.54
- PRALUENT (Drug) $11.22
- NAMZARIC (Drug) $4.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bethel Park
Dr. Brian Deyarmin, M.d, M.D
Family Medicine — Payments: $470,802
Family Medicine $470,802
Dr. Michael Mcgonigal, M.d, M.D
Family Medicine — Payments: $102,866
Family Medicine $102,866
Jennifer Colpo, D.o, D.O
Family Medicine — Payments: $13,774
Family Medicine $13,774
Matthew Portz, M.d, M.D
Family Medicine — Payments: $11,285
Family Medicine $11,285
Dr. Neelum Sharma, M.d, M.D
Family Medicine — Payments: $10,303
Family Medicine $10,303
Dr. Louis Komer, M.d, M.D
Family Medicine — Payments: $8,332
Family Medicine $8,332